Science Explorer Back to mapMap
Discussion
Researcher · F-star (United Kingdom) · United Kingdom

Neil Brewis

Neil Brewis publishes mostly in Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research and CAR-T cell therapy research.

ORCID 0000-0002-8171-9222 OpenAlex
World rank
#746,934
of 7,710,434 ranked researchers
Rank in United Kingdom
#62,533
of 367,258
Works
127
Citations
1.9k
Citations per work
14.7
h-index
19
i10-index 20Top 25% in Oncology
Neil Brewis

What does Neil Brewis research?

Neil Brewis's work is mostly in Medicine (40%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (10%).

Life Sciences: 50 works · 39.7% of their workBiochemistry, Genetics and Molecular Biology: 37 works · 29.4% of their workMolecular Biology: 27 works · 21.4% of their workCell Biology: 5 works · 4.0% of their workGenetics: 5 works · 4.0% of their workImmunology and Microbiology: 13 works · 10.3% of their workImmunology: 13 works · 10.3% of their workHealth Sciences: 50 works · 39.7% of their workMedicine: 50 works · 39.7% of their workOncology: 29 works · 23.0% of their workRadiology, Nuclear Medicine and Imaging: 21 works · 16.7% of their workEverything else: 26 works · 20.6% of their workTHEIR WORKNeil Brewis127works
Life Sciences40%Health Sciences40%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3729.4%
    2. Immunology and Microbiology1310.3%
    1. Medicine5039.7%
  3. Everything else2620.6%
  1. 1Oncology23% of their works
  2. 2Molecular Biology21% of their works
  3. 3Radiology, Nuclear Medicine and Imaging17% of their works
  4. 4Immunology10% of their works
  5. 5Genetics4% of their works
  6. 6Cell Biology4% of their works

Research topics

Which keywords describe Neil Brewis's research?

The keywords of their largest research topics: Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, Fc Receptors, Therapeutic Antibodies, Cancer Immunotherapy, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Tumor Microenvironment212 topics
  2. Immune Checkpoint Blockade181 topic
  3. PD-1 and PD-L1181 topic
  4. Fc Receptors151 topic
  5. Therapeutic Antibodies151 topic
  6. Cancer Immunotherapy142 topics
  7. CAR T Cells81 topic
  8. Chimeric Antigen Receptor81 topic
  9. Dendritic Cells61 topic
  10. Immunity61 topic
  11. PET Imaging51 topic
  12. Radiopharmaceuticals51 topic
  13. Gene Therapy41 topic
  14. Viral Vectors41 topic
  15. Cell Division31 topic
  16. HIF-131 topic
  17. Microtubules31 topic
  18. Warburg Effect31 topic

Where does Neil Brewis work?

Neil Brewis's main affiliation in the publication record is F-star (United Kingdom), United Kingdom.

How many publications and citations does Neil Brewis have?

OpenAlex counts 127 works and 1,867 citations for Neil Brewis, an h-index of 19, ranking #746,934 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Neil Brewis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.